MetaCap

Who Owns Sarepta Therapeutics Stock?

NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.33-0.84 (-5.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
99.31%
Institutional holders
414
  • Institutions 95.2%
  • Insiders 4.8%
  • Public and other 0.0%

Who owns Sarepta Therapeutics stock?

Institutional investors own about 99.3% of Sarepta Therapeutics's shares, spread across 414 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.81% of SRPT.

The largest institutional holders are Blackrock Inc. (17.51%), Vanguard Portfolio Management LLC (8.11%) and State Street Corporation (6.91%). Together, the top 10 institutions control 55.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their SRPT positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of SRPT

Sarepta Therapeutics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.18.78M17.51%-1.1%
Vanguard Portfolio Management LLC8.70M8.11%+3.8%
State Street Corporation7.41M6.91%-16.9%
First Trust Advisors LP4.92M4.59%+12.8%
Vanguard Capital Management LLC4.60M4.29%+0.1%
Two Sigma Investments, LP4.48M4.17%-2.7%
Goldman Sachs Group Inc3.28M3.06%+60.5%
Geode Capital Management, LLC2.69M2.51%-3.1%
Balyasny Asset Management LP2.45M2.29%+1510.6%
Erste Asset Management GmbH2.27M2.12%-11.7%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of SRPT

Sarepta Therapeutics top fund holders
FundShares% Held
iShares Trust-iShares Core S&P Small-Cap ETF6.29M5.86%
First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd.4.78M4.46%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.19M2.97%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.96M2.76%
iShares Trust-iShares Russell 2000 ETF2.69M2.51%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.30M2.14%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.33M1.24%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.20M1.12%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.14M1.06%
Federated Hermes Equity Funds-Federated Hermes MDT Mid Cap Growth Fund1.11M1.03%

Frequently asked questions

Who is the largest shareholder of Sarepta Therapeutics?

Blackrock Inc. is the largest institutional shareholder of SRPT, owning 17.51% of shares outstanding (18.78M shares) as of its latest 13F filing.

What percentage of Sarepta Therapeutics is owned by institutions?

Institutions own about 99.3% of SRPT shares and 104.3% of the public float.

How much of Sarepta Therapeutics do insiders own?

Insiders, such as officers and directors, own about 4.81% of SRPT shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related